COMPOSITES PART B-ENGINEERING
·
2021
·
IF 9.078
Qi Zhao,Xudong Li,Zishang Tian,Hui Ma,Xianglin Hou,Yingxiong Wang,Yuqi Wang
Carbon fiber reinforced bismaleimide resin (CF/BMI) composites are widely used in aerospace field due to their high thermal stability, chemical resistance and excellent mechanical properties . With the large-scale application of CF/BMI composites, it is inevitable to produce a lot of solid wastes, which have a serious impact on the environment, so people have to recycle waste CF/BMI composites. In view of the physical and chemical properties of BMI resin, we developed a green and friendly chemical recovery method of CF/BMI composites by selectively breaking imide bonds for controlled chemical degradation of BMI resin. In 5 wt% NaOH/H 2 O reaction system, the controlled chemical degradation of CF/BMI composites can be realized by selective cleavage of imide bonds, and the 4,4′-Diaminodiphenyl methane (DDM) and 2,2′,2″,2‴-((methylenebis(4,1-phenylene))bis(azanetriyl))tetrasuccinic acid (MBTA) can be recovered, and the carbon fiber (CF) can be recycled at the same time. Under the optimal reaction conditions, the yields of DDM and MBTA reached 6.7 wt% and 27.9 wt% at 180 °C for 8 h, respectively. Meanwhile, CF in CF/BMI composites can be completely recovered, and the tensile strength of recovered carbon fiber (rCF) is about 97.6% of that of virgin carbon fiber (vCF). This work provides a very promising strategy for the recycling of CF/BMI composites. The high value-added CF and chemicals (DDM and MBTA) can be recovered by controlled degradation of CF/BMI composites via selective cleavage of imide bonds.
研究领域:
材料科学
·
环境科学
✓ 已验证
产品关联
DOI
高影响因子
ACS Nano
·
2019
·
IF 13.903
Weidong Nie,Wei Wei,Liping Zuo,Chengliang Lv,Fan Zhang,Gui-Hong Lu,Feng Li,Guanghao Wu,Li−Li Huang,Xiaobo Xi,Hai-Yan Xie
Although adoptive T-cell therapy has been successful in hematological malignancy treatment, its application in solid tumors remains a great challenge. Here, using a pH-sensitive benzoic–imine bond and inverse electron-demand Diels–Alder cycloaddition, we prepared magnetic nanoclusters (NCs) armed with responsive PD-1 antibody (aP), which could then bind onto effector T cells due to their PD-1 expression. After adoptive transfer, the magnetization and superparamagnetism of NCs enabled us to magnetically recruit effector T cells and aP simultaneously to tumor sites with MRI guidance. Owing to the acidic intratumoral microenvironment, the benzoic–imine bond then hydrolyzed, leading to the release of aP. The therapeutic effects of adoptive T cells and free aP could thus be spatiotemporally coupled. As a result, we achieved inhibition of tumor growth with few side effects, demonstrating the great promise of such a chemical approach for safe and high-performance adoptive T-cell therapy against solid tumors.
研究领域:
癌症免疫治疗
·
纳米技术
·
生物医学工程
·
分子生物学
✓ 已验证
产品关联
DOI
PubMed
高影响因子
Nanoscale
·
2016
·Vol. 8
·期 20
·10832-10842
·
IF 7.76
Caiyan Zhao,Hongzhang Deng,Jing Xu,Shuyi Li,Lin Zhong,Leihou Shao,Yan Wu,Xing-jie Liang
PEGylated lipids confer longer systemic circulation and tumor accumulation via the enhanced permeability and retention (EPR) effect. However, PEGylation inhibits cellular uptake and subsequent endosomal escape. In order to balance the contradiction between the advantages of long circulation and the disadvantages of poor uptake of PEGylated lipids, we prepared a “sheddable” PEG-lipid micelle system based on the conjugation of PEG and phosphatidyl ethanolamine (DSPE) with a pH sensitive benzoic imine bond. In a physiological environment, the PEG-protected micelles were not readily taken up by the reticuloendothelial system (RES) and could be successfully delivered to tumor tissue by the EPR effect. In a tumor acidic microenvironment, the PEG chains detached from the surfaces of the micelles while the degree of linker cleavage could not cause a significant particle size change, which facilitated the carrier binding to tumor cells and improved the cellular uptake. Subsequently, the “sheddable” PEG-lipid micelles easily internalized into cells and the increased acidity in the lysosomes further promoted drug release. Thus, this “sheddable” PEG-lipid nanocarrier could be a good candidate for effective intracellular drug delivery in cancer chemotherapy.
研究领域:
药剂学
·
纳米技术
·
肿瘤学
·
药物递送系统
✓ 已验证
产品关联
DOI
PubMed
高影响因子
危险品化学品经营许可证（带存储）